Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.10.09.681407

Hybrids reveal accessible chromatin trans genetic associations

Abstract

Crosses between genetically distant Zea mays (Maize) inbreds cause hybrid vigour (heterosis): an over-dominant increase in vegetative growth and grain yield. Although the contributing loci are unknown, heterosis strength varies polygenically, with crosses between stiff stalk and non-stiff stalk lineages often producing the highly heterotic F1 seed used for agriculture. As F1 genomes conserve the parental cis-regulatory state, F1 trans-interactions between haplotypes underpin F1 trait over-dominance and heterotic gene expression. Gene expression relies upon transcription factors binding cis-regulatory elements in accessible chromatin regions (ACRs) and recruiting RNA POLYMERASE II. Here, assay for transposase accessible chromatin sequencing (ATAC-seq) examined cis-regulatory element chromatin accessibility inheritance in three different F1 parent-offspring pairs, including a representative stiff stalk-by-non-stiff stalk (B73xOh43) cross. Using concatenated reference alignment, we categorized ACR modes of inheritance (additive, dominant, under/over-dominant), revealing that ACRs are largely inherited additively, and, concordantly, that chromatin accessibility has strong narrow-sense heritability. However, mirroring other heterotic phenotypes, the B73xOh43 cross exhibited the most dominant and over-dominant inheritance. Comparing allele-specific parent-to-offspring chromatin accessibility, we identified F1 differentially trans-regulated ACRs. Using a matched chromatin accessible diversity panel, we found B73xOh43 SNPs with more ACR trans-associations than expected due to chance. These trans-regulatory variants revealed how cell-division and anabolism are elevated in heterotic F1 seedlings. This multiple discovery filtering (MDF) approach to trans-regulatory variant detection is genomic modality agnostic and stands to empower trans-relationship dissection in diverse genetic models.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Minow, M. A. A., Marand, A. P., Zhang, X., Meyer, C. A., Pelkmans, J., Schmitz, R. J.. 2025-10-10. Hybrids reveal accessible chromatin trans genetic associations. https://doi.org/10.1101/2025.10.09.681407

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗